Aspen Aerogels, Inc. ASPN R2K
Company Overview
Aspen Aerogels, Inc., an aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America. It operates through two segments: Thermal Barrier and Energy Industrial. The company offers PyroThin aerogel thermal barriers for use in battery packs in EVs; Pyrogel XTE for refineries and petrochemical facilities; Pyrogel HPS for high temperatures and in demanding thermal applications in refining and chemical processing systems; Pyrogel XTF for protection against fire; Cryogel Z for sub-ambient and cryogenic applications; Spaceloft Subsea for pipe-in-pipe applications in offshore oil production; and Cryogel X201 for cold system designs. It serves EV manufacturers, automotive suppliers, lithium-ion battery manufacturers, and e-mobility and energy storage companies. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.
Why Investors Should Care
Revenue has grown at a 12.9% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $271.10M (-40.1% YoY); net profit $-389.55M.
- Trailing 12 Months Year-on-year growth — revenue -51.9%, earnings -3012.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 12.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 12.86% |
| 1 Year: | -51.90% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -3,012.54% |
Stock Price Performance
| 1 Year: | -19.33% |
| 6 Months: | +57.74% |
| 3 Months: | +60.12% |
| 1 Month: | -10.47% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)44.95 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 12.9% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 39.9% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ASPN Aspen Aerogels, Inc. R2K | 5.30 | -3.93 | $439.25M | 0.00% | -14.91% | -42.40% | 12.86% | - |
| 2 | CAT Caterpillar Inc. SPX | 914.30 | 45.35 | $421.12B | 0.70% | 17.98% | 51.33% | 2.29% | 5.24% |
| 3 | GE GE Aerospace SPX | 360.35 | 44.65 | $375.97B | 0.53% | 11.89% | 45.43% | 16.32% | 195.89% |
| 4 | GEV GE Vernova Inc. SPXAI | 1,055.28 | 30.18 | $283.57B | 0.19% | 6.30% | 75.71% | 8.68% | - |
| 5 | RTX RTX Corporation SPX | 195.89 | 36.68 | $263.80B | 1.51% | 8.28% | 11.57% | 2.61% | 2.62% |
| 6 | BA The Boeing Company SPX | 218.12 | 85.87 | $171.94B | 0.00% | -9.01% | - | 1.67% | -3.28% |
| 7 | UNP Union Pacific Corporation SPX | 288.36 | 23.75 | $171.20B | 1.91% | 15.22% | 40.69% | 2.30% | 7.77% |
| 8 | ETN Eaton Corporation plc SPXAI | 412.86 | 39.13 | $160.31B | 1.06% | 11.53% | 20.84% | 4.73% | 10.38% |
| 9 | DE Deere & Company SPX | 589.48 | 33.40 | $159.22B | 1.11% | - | 18.35% | 3.43% | 5.10% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | 23.00M | 25.07M | 27.20M | 36.36M | 23.07M | 21.67M | 23.94M | 35.68M | 27.91M | 29.53M | 35.42M | 46.51M | 28.42M | 24.64M | 24.20M | 23.02M | 28.10M | 31.67M | 30.38M | 38.41M | 45.64M | 36.71M | 45.59M | 48.16M | 60.76M | 94.50M | 117.77M | - | - | 78.72M | 78.02M | 73.02M | 41.34M | 37.88M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 55.91M | 52.71M | 52.22M | 64.27M | 33.61M |
| Gross Profit | 5.17M | 9.85M | 6.53M | 6.65M | 6.40M | 3.73M | 2.22M | 3.69M | 4.95M | 7.81M | 2.81M | 2.74M | 1.53M | 5.59M | 3.72M | 3.51M | 7.74M | 11.31M | 5.98M | 2.85M | 1.90M | 3.86M | 3.96M | 4.58M | 3.07M | -1.79M | -1.21M | -6.36M | 5.09M | 8.41M | 13.81M | 35.14M | 51.58M | - | - | 22.81M | 25.32M | 20.80M | -22.93M | 4.28M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.75M | 24.58M | 22.58M | 24.48M | 24.68M |
| Operating Income | -2.48M | 1.68M | -1.76M | -1.35M | -2.40M | -5.71M | -9.05M | -5.43M | -3.03M | -1.62M | -6.75M | -6.86M | -6.37M | -13.94M | -5.96M | -5.21M | -2.15M | -830.00K | -3.09M | -5.65M | -6.70M | -6.13M | -6.17M | -6.61M | -11.50M | -18.62M | -22.65M | -28.31M | -18.91M | -17.04M | -14.63M | 2.44M | 19.99M | - | - | -2.94M | 738.00K | -1.78M | -47.41M | -20.41M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -292.42M | 641.00K | 2.62M | -42.13M | -15.41M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.96M | 3.08M | 2.97M | 2.70M | 3.15M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -300.17M | -8.23M | -5.74M | -73.01M | -23.94M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08M | 821.00K | 594.00K | -97.00K | -253.00K |
| Net Income | -2.52M | 1.64M | -1.80M | -1.39M | -3.10M | -5.74M | -9.08M | -5.47M | -3.09M | -1.68M | -6.84M | -6.96M | -6.53M | -14.11M | -6.00M | -5.32M | -2.29M | -956.00K | -3.17M | -5.70M | -6.75M | -6.19M | -6.25M | -6.67M | -7.82M | -19.48M | -24.05M | -29.59M | -16.80M | -15.42M | -13.07M | -1.83M | 16.82M | - | - | -301.25M | -9.06M | -6.33M | -72.91M | -23.69M |
| Diluted EPS | -0.11 | 0.07 | -0.08 | -0.06 | -0.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.23 | -0.24 | -0.59 | -0.68 | -0.75 | -0.24 | -0.22 | -0.19 | -0.02 | 0.21 | - | - | -3.67 | -0.11 | -0.08 | -0.88 | -0.29 |
| R&D Expense | 1.15M | - | 1.31M | 1.29M | 1.33M | - | 1.58M | 1.71M | 1.47M | - | 1.60M | 1.64M | 1.38M | - | 1.93M | 1.87M | 2.05M | - | 2.23M | 2.12M | 2.09M | - | 2.44M | 2.61M | 3.08M | 3.59M | 4.45M | 4.69M | 4.10M | 3.96M | 4.22M | 4.49M | 4.57M | 4.59M | - | 4.33M | 3.79M | 2.49M | - | 2.72M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63.45M | 86.09M | 102.40M | 122.52M | 117.74M | 111.63M | 104.36M | 139.38M | 100.27M | - | 180.36M | 238.72M | 452.70M | 271.10M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | 175.39M | 181.80M | 269.80M | 225.10M |
| Gross Profit | -7.97M | 10.73M | 17.08M | 24.65M | 23.31M | 18.67M | 12.67M | 26.28M | 14.59M | - | 4.98M | 56.92M | 182.90M | 46.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | 84.22M | 106.12M | 124.85M | 97.39M |
| Operating Income | -32.97M | -19.97M | -16.04M | -6.24M | -11.22M | -19.14M | -33.92M | -14.16M | -21.57M | - | -79.25M | -49.20M | 58.05M | -51.39M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | -68.41M | -25.16M | 49.57M | -331.29M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | 5.11M | 5.33M | 11.96M | 10.72M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | -82.74M | -45.81M | 15.09M | -387.16M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 1.71M | 2.39M |
| Net Income | -56.14M | -47.61M | -66.32M | -6.42M | -12.02M | -19.32M | -34.44M | -14.56M | -21.81M | - | -82.74M | -45.81M | 13.38M | -389.55M |
| Diluted EPS | -2,851.08 | 410.56 | -5.37 | -0.28 | - | - | - | - | -0.83 | - | -2.10 | -0.66 | 0.17 | -4.73 |
| R&D Expense | 5.14M | 5.16M | 5.98M | 5.25M | 5.31M | 6.18M | 6.32M | 8.41M | 8.73M | 11.44M | 16.93M | 16.36M | 18.05M | 13.42M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 90.23M | 145.04M | 140.07M | 134.67M | 123.81M | 99.02M | 103.50M | 97.42M | - | 643.42M | 703.05M | 895.14M | 406.68M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | 369.69M | 266.33M | 409.45M | 242.05M |
| Cash & Equivalents | 11.24M | 1.34M | 1.57M | 49.72M | 32.80M | 18.09M | 10.69M | 3.33M | 3.63M | 16.50M | - | 281.33M | 139.72M | 220.88M | 156.86M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | 22.54M | 39.19M | 47.55M | 38.25M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | 57.35M | 70.00M | 109.10M | 35.27M |
| Total Liabilities | - | - | 152.20M | 21.33M | 17.60M | 19.11M | 22.87M | 28.77M | 44.51M | 29.57M | - | 195.98M | 214.99M | 280.44M | 171.16M |
| Current Liabilities | - | - | 31.39M | 20.21M | 17.41M | 18.13M | 21.57M | 23.07M | 30.43M | 13.93M | - | 78.94M | 78.09M | 110.11M | 62.02M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | 2.06M | - | 103.58M | 114.99M | 137.09M | 79.80M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | 119.40M | 138.77M | 197.38M | 143.71M |
| Total Equity | -113.51M | -120.80M | -61.97M | 123.72M | 122.47M | 115.56M | 100.94M | 70.25M | 58.99M | 67.85M | - | 447.44M | 488.06M | 614.71M | 235.52M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 69.99M | 76.50M | 82.04M | 82.71M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -578.00K | -4.61M | -8.65M | -1.05M | -9.92M | - | -94.40M | -42.61M | 45.55M | 32.87M |
| Investing Cash Flow | - | - | - | - | -13.22M | -6.12M | -3.59M | -2.11M | -3.42M | - | -177.97M | -175.46M | -86.26M | -37.45M |
| Financing Cash Flow | - | - | - | - | -924.00K | 3.33M | 4.88M | 3.47M | 26.20M | - | 478.37M | 75.48M | 122.02M | -58.13M |
| Capital Expenditure | -10.24M | -3.33M | -13.24M | -21.96M | -13.22M | -6.12M | -3.59M | -2.11M | -3.42M | - | -177.97M | -175.46M | -86.26M | -37.45M |
| Free Cash Flow | - | - | - | - | -13.79M | -10.72M | -12.25M | -3.17M | -13.34M | - | -272.37M | -218.07M | -40.71M | -4.58M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | 206.00M | -142.59M | 81.31M | -62.71M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | -12.6% | 12.5% | 16.7% | 20.1% | 19.8% | 16.7% | 12.1% | 18.9% | 14.6% | - | 2.8% | 23.8% | 40.4% | 17.0% |
| Operating Margin % | -52.0% | -23.2% | -15.7% | -5.1% | -9.5% | -17.1% | -32.5% | -10.2% | -21.5% | - | -43.9% | -20.6% | 12.8% | -19.0% |
| Net Margin % | -88.5% | -55.3% | -64.8% | -5.2% | -10.2% | -17.3% | -33.0% | -10.5% | -21.7% | - | -45.9% | -19.2% | 3.0% | -143.7% |
| ROE % | 46.5% | 76.8% | -53.6% | -5.2% | -10.4% | -19.1% | -49.0% | -24.7% | -32.1% | - | -18.5% | -9.4% | 2.2% | -165.4% |
| ROCE % | - | -33.9% | -12.9% | -5.1% | -9.6% | -18.7% | -44.7% | -19.4% | -25.8% | - | -14.0% | -7.9% | 7.4% | -14.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Kim, LLC | 14.82% | 12.28M | $64.72M |
| 2 | Oaktop Capital Management II, L.P. | 6.24% | 5.17M | $27.24M |
| 3 | Blackrock Inc. | 5.72% | 4.74M | $25.00M |
| 4 | Needham Investment Management, L.L.C. | 5.45% | 4.52M | $23.81M |
| 5 | Vanguard Capital Management LLC | 4.15% | 3.44M | $18.11M |
| 6 | George Kaiser Family Foundation | 3.82% | 3.17M | $16.69M |
| 7 | State Street Corporation | 2.80% | 2.32M | $12.23M |
| 8 | Invesco Ltd. | 2.77% | 2.30M | $12.11M |
| 9 | Gagnon Securities, LLC | 2.25% | 1.86M | $9.81M |
| 10 | Rice, Hall, James & Associates LLC | 1.87% | 1.55M | $8.18M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ASPN
Beerenberg Prevails in Patent Case Against Aspen Aerogels
SEOUL, South Korea, June 28, 2026--The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material.
Aspen Aerogels Named a 2025 Supplier of the Year by General Motors
NORTHBOROUGH, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in aerogel-based sustainability and electrification solutions, today announced that it has been named a…
How The Aspen Aerogels (ASPN) Investment Story Is Shifting With Mixed Analyst Views
Aspen Aerogels is back in focus after analysts updated their price targets, with one group lifting theirs by US$1 and another cutting theirs to US$3 from US$4. The split views mirror a broader debate, where more optimistic analysts point to…
Aspen Aerogels Begins Staged Restart of East Providence Facility
NORTHBOROUGH, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced the successful initiation of a staged restart of its manufacturing operations at its East Providence, Rhode I…
Aspen Aerogels Q1 Earnings Call Highlights
Aspen Aerogels (NYSE:ASPN) said it expects revenue to improve sequentially through 2026 despite a first-quarter sales decline, a temporary shutdown at its East Providence, Rhode Island, manufacturing facility and continued volatility in ele…
Aspen Aerogels, Inc. Q1 2026 Earnings Call Summary
Moby summary of Aspen Aerogels, Inc.'s Q1 2026 earnings call
ASPN — Frequently Asked Questions
What is the current share price of Aspen Aerogels, Inc. (ASPN)?
As of 2026-07-15 16:51 PDT, Aspen Aerogels, Inc. (ASPN) trades at $5.30 on NYSE. Its 52-week range is $2.57 to $8.82.
What is the market capitalisation of ASPN?
Aspen Aerogels, Inc. (ASPN) has a market capitalisation of $439.25M on NYSE.
What is the P/E ratio of ASPN?
ASPN trades at a trailing price-to-earnings (P/E) ratio of -3.93. The industry average P/E is 30.16. Its price-to-book (P/B) ratio is 2.04.
What is the return on equity (ROE) of ASPN?
ASPN has a return on equity (ROE) of -42.40%. Its return on capital employed (ROCE) is -14.91%.
Is ASPN a good stock to buy?
This page provides a data-driven analysis of Aspen Aerogels, Inc. (ASPN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.